Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.1K Buy
67
+19
+40% +$870 ﹤0.01% 2869
2026
Q2
$1.57K Hold
48
– – ﹤0.01% 3042
2026
Q1
$1.7K Hold
48
– – ﹤0.01% 2636
2025
Q4
$1.95K Hold
48
– – ﹤0.01% 2643
2025
Q3
$2.26K Hold
48
– – ﹤0.01% 2441
2025
Q2
$2.5K Hold
48
– – ﹤0.01% 2252
2025
Q1
$2.9K Hold
48
– – ﹤0.01% 2210
2024
Q4
$3.28K Hold
48
– – ﹤0.01% 2138
2024
Q3
$3.45K Buy
+48
New +$3.39K ﹤0.01% 2135

Other funds holding CNMD

BFC Planning's CNMD Position: Q3 2026 in Review

BFC Planning increased its CONMED (CNMD) stake by 40% in Q3 2026, buying an estimated $870 and bringing the position to 67 shares worth $3.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2869.

BFC Planning first reported a position in CNMD in Q3 2024 and has held it in 9 quarters since. The position peaked at $3.45K in Q3 2024. 213 funds tracked by Wall St. Rank hold CNMD as of Q3 2026.

  • BFC Planning held 67 shares of CONMED worth $3.1K as of Q3 2026.
  • BFC Planning bought 19 CONMED shares in Q3 2026, an estimated $870.
  • CONMED made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2869 holding.
  • BFC Planning first reported a position in CONMED in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's CONMED position peaked at $3.45K in Q3 2024.
  • 213 funds tracked by Wall St. Rank held CONMED as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.